A machine learning tool incorporating both clinical and genomic data helps predict response to CDK4/6 inhibitor therapy in HR+/HER2– advanced breast cancer.

Medscape

United States

Can AI Tool Guide CDK4/6 Inhibitor Use in Breast Cancer?

Healthing.ca

Toronto

Ontario

Canada

Diverse voices shape key issues in Breast Cancer Canada progress report: 'We know that early detection saves lives'

Breast cancer detection: Breast cancer is becoming a big threat in India. Every year lakhs of women are falling prey to it. Delhi's AIIMS is working on AI technology for early detection of breast cancer. Tests like mammogram are being done with the help of AI and studies are also going on on it. Now the help of ASHA workers will also be taken for breast cancer detection. ASHA workers take care of the vaccination work in remote villages and towns…

Breast cancer detection : ભારતમાં સ્તન કેન્સર એક મોટો ખતરો બની રહ્યો છે. દર વર્ષે લાખો મહિલાઓ આનો શિકાર બની રહી છે. દિલ્હીની AIIMS બ્રેસ્ટ કેન્સરની વહેલી તપાસ માટે AI ટેક્નોલોજી પર કામ કરી રહી છે. AIની મદદથી મેમોગ્રામ જેવા ટેસ્ટ કરવામાં આવી રહ્યા છે અને તેના પર અભ્યાસ પણ ચાલી રહ્યો છે. હવે બ્રેસ્ટ કેન્સરની તપાસ માટે આશા વર્કરોની પણ મદદ લેવામાં આવશે. આશા વર્કરો દૂરના ગામડાઓ અને નગરોમાં રસીકરણની કામગીરીનું ધ્યાન રાખે છે. હવે તે આ વિસ્તારોમાં જશે અ…

Breast Cancer : હવે બ્રેસ્ટ કેન્સર સરળતાથી ઓળખી શકાશે, દિલ્હી AIIMS લેશે આશા વર્કર અને AIની મદદ

tv9gujarati.com

Breast Cancer: Now breast cancer can be easily identified, Delhi AIIMS will take help of ASHA workers and AI

Lasofoxifene plus abemaciclib is set to be evaluated in ESR1-mutated ER+/HER2– metastatic breast cancer in the phase 3 ELAINEIII trial.

onclive.com

Lasofoxifene Aims to Amplify Efficacy of Abemaciclib in ESR1-Mutated ER+/HER2– Metastatic Breast Cancer

Durham – Ductal carcinoma in situ (DCIS), a common precancerous condition detected by mammography, may not require immediate surgery. In a randomized trial, active monitoring with twice-yearly mammograms did not reduce the risk of DCIS.

Durham – Das duktale Carcinoma in situ (DCIS), eine häufige bei der Mammografie entdeckte Krebsvorstufe, erfordert möglicherweise keine sofortige Operation. In einer randomisierten Studie kam es unter einem aktiven Monitoring mit 2-mal jährlichen Mammografien nicht...

Mammakarzinom: Aktives Monitoring bei DCIS in den ersten zwei Jahren sicher

Deutsches Ärzteblatt

Breast cancer: Active monitoring of DCIS in the first two years is safe

Explore how the integration of AI-generated features into clinical practice could revolutionise breast cancer screening

European Medical Journal

AI Enhances Breast Cancer Prediction

SABCS 2024 saw a variety of potentially practice-changing findings on novel antibody drug conjugates, biomarker data, and surgical interventions.

cancernetwork.com

Top 10 Findings Shaping the Future of Breast Cancer Care From SABCS 2024

Targeting the estrogen receptor and HER2 pathways improved progression-free survival in patients with HR-positive, HER2-positive metastatic breast cancer.

curetoday.com

Targeting Multiple Pathways Improves Outcomes in Some With Metastatic Breast Cancer

In the first of a three-part interview from the recent RSNA conference, Mark Traill, M.D., discusses current challenges in breast radiology and the potential of AI to help mitigate some of these issues.

diagnosticimaging.com

Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1

tim.hodson Wed, 12/18/2024 - 11:59 Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced that four novel AI-driven breast cancer research abstracts were accepted for presentation at the 2024 San Antonio Breast Cancer Symposium (SABCS). These clinical abstracts highlight the latest research in breast health AI, focusing on improving detection and risk prediction accuracy and assessing…

Can AI Tool Guide CDK4/6 Inhibitor Use in Breast Cancer?

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics